{"editorial":{"content_id":"870d6e1d-4308-425c-905e-4cdcc0ce4764","slug":"sindusfarma-datafolha-20261103-1114d8","content_type":"news","title":"Sindusfarma与Datafolha将发布拉美首个制药行业普查，覆盖88%市场","summary":"巴西制药工业工会Sindusfarma与Datafolha将于11月11日发布拉美首个制药行业普查，汇集168家企业信息，覆盖88%市场。","body":"巴西制药工业工会Sindusfarma与Datafolha将于11月11日发布拉丁美洲首个制药行业普查。该调查汇集168家国内外企业的信息，覆盖88%的市场，旨在梳理行业结构、投资与挑战，为公共政策和战略决策提供依据。\n\n调查于2025年11月至2026年3月期间进行，动员500多名专业人员，包含139个问题，涵盖领导力、人力资源、销售团队、生产、临床研究和财务。结果将在里约热内卢的Rio Health Forum上公布。\n\n该调查旨在扩大对制药行业运作的了解，并推动关于投资、创新和生产发展的讨论。诊断结果还可帮助确定融资、研究激励、技术转让和专业人员培训等领域的优先事项。\n\nSindusfarma执行主席Nelson Mussolini表示，这些数据应能提升与政府的对话质量，并帮助引导针对该行业的措施。他说：“全面的诊断将使我们能够提升与政府的对话，识别发展机遇，并讨论更符合行业需求的措施。目标是助力做出加强生产和创新的决策，同时不忽视民众获得药品的机会。”\n\n此次调查正值关于药品领域生产自主性和减少对外依赖的讨论之际。Sindusfarma代表652家国内外企业，占巴西药品市场95%以上。","why_it_matters":null,"cbi_observation":null,"direction_tag":"巴西","primary_category":"科技平台","secondary_topics":["行业趋势","政策","市场进入","br-health"],"content_level":"编辑整理","event_type":"行业趋势","audience_tags":[],"event_location":null,"verification_status":"unverified","published_at":"2026-11-03T23:03:17.258Z","display_date":"2026-11-03","source_published_at":null,"source_url":"https://panoramafarmaceutico.com.br/sindusfarma-anuncia-censo-da-industria-farmaceutica/","source_name":"Panorama Farmacêutico","source_language":"pt","author_name":"编辑部","risk_level":"medium","risk_flags":[],"opportunity_flags":[],"trend_signals":[]},"intelligence":null,"meta":{"canonical_url":"https://chinabrazilinsight.com/news/sindusfarma-datafolha-20261103-1114d8","api_url":"https://chinabrazilinsight.com/api/public/content/sindusfarma-datafolha-20261103-1114d8","markdown_url":"https://chinabrazilinsight.com/api/public/content/sindusfarma-datafolha-20261103-1114d8?view=markdown","json_url":"https://chinabrazilinsight.com/api/public/content/sindusfarma-datafolha-20261103-1114d8?view=json","last_updated":"2026-11-03T23:03:41.464Z","platform":"China Brazil Insight","platform_url":"https://chinabrazilinsight.com"}}